Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01504347
Show Display Options
Rank Status Study
1 Completed Phase 1/2 Lyme Vaccine Study
Condition: Prophylaxis of Lyme Borreliosis
Intervention: Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine

Indicates status has not been verified in more than two years